- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06988995
- Original Trial
Compassion Strikes Back
Compassion Strikes Back: Improving Dyadic Quality of Life for LVAD Patients and Caregivers
Research has shown that LVAD patients and their caregivers typically experience increased mental health concerns and decreased quality of life following LVAD implantation and hospital discharge. The purpose of this study is to explore how to improve quality of life for LVAD patients and their caregivers in the initial transition from hospital to home after LVAD implantation.
Over the course of the study, participants will complete 2 surveys: one when participants are in the hospital and one at a 2-month post-hospital follow-up appointment with the participants' cardiologist. Participants may be contacted if there is data missing from surveys.
Participants may also be provided with information on improving mental health in the form of handouts or a brief meeting with a psychology provider.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32605
- Recruiting
- University of Florida
-
Contact:
- Abigail Shonrock, PhD
- Phone Number: 610-772-6099
- Email: ashonrock@ufl.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- LVAD implantation or caregiver or patient with LVAD; over 18 years old; primary caregiver is a family member
Exclusion Criteria:
- Currently or in the past 3 months received psychotherapy or psychosocial or peer support; hospitalized for psychiatric reasons in the past 6 months; current, active suicidal thoughts or a reported suicide attempt within the past year; a current alcohol/substance use disorder that required immediate treatment; or a current or past thought disorder, psychosis, or unmanaged bipolar disorder; enrolled in another investigational research/clinical trial; toxic/negative dynamic between pt and caregiver; extended post-LVAD implantation course (i.e., more than 2 months in the hospital).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Information
|
Participants provided handouts with information on self-compassion
|
|
Experimental: Meeting
|
Participants meet with a psychological provider to receive information on self-compassion and training on how to utilize self-compassion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-compassion
Time Frame: 2 months
|
Level of self-compassion a participant reports using the Self-Compassion Scale - Short Form (Raes et al., 2011).
Scores range from 1-5.
|
2 months
|
|
QOL
Time Frame: 2 months
|
Quality of Life will be measured using the 16 item Quality of Life Scale (Burckhardt et al., 1989).
Scores range from 16-112, with higher scores indicating higher levels of quality of life.
|
2 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
NYHA
Time Frame: 2 months
|
2 months
|
|
|
Cardiac Self-Efficacy
Time Frame: 2 months
|
The Cardiac Self-Efficacy Scale (Sullivan et al., 1998) is a 13-item measure that measures self-efficacy in patients with cardiac problems across 2 subscales: maintain and control.
Scores are averaged across the two subscales.
Scores range from 0-4, with higher scores indicating higher confidence or perceived self-efficacy.
|
2 months
|
|
General Self-Efficacy
Time Frame: 2 months
|
General Self-efficacy will be measured by the General Self-Efficacy Scale (Weinman et al., 1995).
The GSE is a 10-item scale with scores ranging from 10-40, with higher scores indicating more self-efficacy.
|
2 months
|
|
Illness Denial
Time Frame: 2 months
|
Illness denial will be measured using the Illness Denial Questionnaire.
Caregivers will receive the caregiver version, and patients will receive the patient version.
Both versions are 24-items, with scores ranging from 0-24.
Higher scores indicate higher levels of denial
|
2 months
|
|
Perceived Stress Scale
Time Frame: 2 months
|
2 months
|
|
|
Caregiver Burden
Time Frame: 2 months
|
Caregiver burden will be assessed using the Zarit Burden Interview - Short Form, which is a 12 item questionnaire assessing caregiver burden.
Scores range from 0-48, with a score over 20 indicating high burden.
|
2 months
|
|
Acceptability & Feasibility of Intervention
Time Frame: 2 months
|
Participants will be asked about the feasibility and acceptability of the intervention they receive.
Scores range from 0-5, with higher scores indicating greater acceptability and higher feasibility (i.e., the intervention felt easy to complete and use).
|
2 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB202500512
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.